TScan Therapeutics Inc. (TCRX) Revenue Analysis | Historical Sales Growth & Trends - Stocknear

TScan Therapeutics Inc.

NASDAQ: TCRX · Real-Time Price · USD
1.91
0.02 (1.06%)
At close: Sep 05, 2025, 3:59 PM
1.92
0.52%
After-hours: Sep 05, 2025, 07:32 PM EDT

TScan Therapeutics Revenue

TScan Therapeutics reported an annual revenue of $2.82M, reflecting a -86.62% growth. For the quarter ending June 30, 2025, TScan Therapeutics generated $3.08M in revenue.
Revenue (ttm)
2.82M
Revenue Growth
-86.62%
Price / Sales Ratio
120.9
Revenue / Employee
14.08K
Employees
200
Market Cap
108.09M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 2.82M -86.62%
Dec 31, 2023 21.05M +55.52%
Dec 31, 2022 13.54M +33.47%
Dec 31, 2021 10.14M +834.65%
Dec 31, 2020 1.08M +Infinity%
Dec 31, 2019 0 n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.